Brief: Cinclus Pharma Q2 2026 EBIT Loss At SEK 95.03 Mln
19/08/2026 07:07
BRIEF-Cinclus Pharma Q2 2026 EBIT Loss At SEK 95.03 Mln Aug 19 (Reuters) - Cinclus Pharma Holding publ AB CINPHA.ST:
Q2 2026 OPERATING PROFIT (EBIT) AMOUNTED TO TSEK -95,031
Q2 2026 NET SALES AMOUNTED TO TSEK 1,766
Source text: ID:nMFN5hf4sw
Further company coverage: CINPHA.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))